Devine L, Lightman S L, Greenwood J
Institute of Ophthalmology, University College London, UK.
Immunology. 1996 Jul;88(3):456-62. doi: 10.1046/j.1365-2567.1996.d01-666.x.
The blood-retinal barrier (BRB), which is composed of the retinal pigment epithelium (RPE) and retinal vascular endothelium, normally restricts the traffic of lymphocytes into the retina. During ocular inflammatory conditions such as posterior uveitis there is a large increase in lymphocyte migration across the BRB. The differential role played by the two barrier sites, however, remains unclear. To evaluate the role of the posterior BRB, the migration of CD4+ antigen-specific T-cell line through rat RPE cell monolayers was investigated in vitro using time-lapse videomicroscopy. The adhesion molecules involved in controlling transepithelial migration across normal and interferon-gamma (IFN-gamma)-activated RPE was assessed with monoclonal antibodies directed against cell adhesion molecules. Lymphocytes were treated with antibodies specific for CD11a (alpha L subunit of LFA-1), CD18 (beta 2 subnit of the leucam family) and CD49 d (alpha 4 subnit of very late activation antigen-4, VLA-4), and the RPE with antibodies specific for CD54 (intracellular adhesion molecule-1, ICAM-1) and CD 106 (vascular cell adhesion molecule-1, VCAM-1). Migration across unstimulated RPE was inhibited by antibodies to ICAM-1 (48.6 +/- 3.5% reduction), leucocyte functional antigen-1 (LFA-1) alpha (61 +/- 5.2%) and LFA-1 beta (63.2 +/- 4.7%), but not by antibodies to VLA-4. VCAM-1 was not expressed on untreated RPE. Following activation of the RPE monolayers for 72 hr with IFN-gamma, antibodies to LFA-1 alpha, LFA-1 beta and ICAM-1 inhibited migration by 49.9 +/- 9.4%, 63.6 +/- 5.5% and 47.7 +/- 4.2% respectively. Antibodies to VLA-4 and VCAM-1 blocked migration by 21.5 +/- 8.4% and 32.3 +/- 6.2%, respectively, which correlated with the induction of VCAM-1 expression on RPE and increased migration. Under these conditions blocking both VCAM-1 and ICAM-1 reduced migration by 70.9 +/- 2.3%, which was greater than the effect of blocking either of these molecules alone. These results demonstrate that the posterior barrier of the BRB utilizes the same principle receptor-ligand pairings in controlling lymphocyte traffic into the retina as the vascular endothelium of the anterior BRB.
血视网膜屏障(BRB)由视网膜色素上皮(RPE)和视网膜血管内皮组成,通常会限制淋巴细胞进入视网膜。在眼部炎症性疾病如后葡萄膜炎期间,淋巴细胞穿过BRB的迁移会大幅增加。然而,这两个屏障部位所起的不同作用仍不清楚。为了评估后BRB的作用,使用延时视频显微镜在体外研究了CD4 +抗原特异性T细胞系通过大鼠RPE细胞单层的迁移。用针对细胞粘附分子的单克隆抗体评估参与控制跨正常和干扰素-γ(IFN-γ)激活的RPE的跨上皮迁移的粘附分子。用针对CD11a(LFA-1的αL亚基)、CD18(白细胞粘附分子家族的β2亚基)和CD49 d(极晚期活化抗原-4,VLA-4的α4亚基)的特异性抗体处理淋巴细胞,并用针对CD54(细胞间粘附分子-1,ICAM-1)和CD 106(血管细胞粘附分子-1,VCAM-1)的特异性抗体处理RPE。抗ICAM-1抗体(减少48.6±3.5%)、白细胞功能抗原-1(LFA-1)α(61±5.2%)和LFA-1β(63.2±4.7%)抑制了跨未刺激RPE的迁移,但抗VLA-4抗体则没有。未处理的RPE上未表达VCAM-1。在用IFN-γ将RPE单层激活72小时后,抗LFA-1α、LFA-1β和ICAM-1抗体分别将迁移抑制了49.9±9.4%、63.6±5.5%和47.7±4.2%。抗VLA-4和VCAM-1抗体分别将迁移阻断了21.5±8.4%和32.3±6.2%,这与RPE上VCAM-1表达的诱导和迁移增加相关。在这些条件下,同时阻断VCAM-1和ICAM-1可将迁移减少70.9±2.3%,这比单独阻断这两种分子中的任何一种的效果都要大。这些结果表明,BRB的后屏障在控制淋巴细胞进入视网膜的过程中利用了与前BRB的血管内皮相同的主要受体-配体配对。